Dr. Yanmin Zhang is a Full Professor at the School of Pharmacy, Health Science Center, Xi’an Jiaotong University, China. He earned his B.S. in Chemistry and Ph.D. in Pharmaceutical Sciences, and launched his independent research program in 2008. Currently, he serves as the Director of the Program for Targeted Drug Screening & Analysis and Tumor Pharmacology. He has presided over more than 30 research projects, authored over 210 peer-reviewed articles including PNAS, Drug Resist Update, Adv Sci, J Adv Res, Adv Mater, ACS Nano, Pharmacol Therapeut, Cancer Lett, and Pharmacol Res. In addition, Dr. Zhang holds multiple editorial positions: Executive Vice Editor-in-Chief of Journal of Pharmaceutical Analysis, Associate Editor of Frontiers in Pharmacology, and Editorial Board Member of Biosensors and Oncology Reports, et al.